 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
|
|
|
|
Phase III
|
|
|
|
COG-AOST0331
AOST0331, NCT00134030, ISRCTN67613327, EU-20530, MRC-EURAMOS1, MRC-BO08, EUDRACT-2004-000242-20
|
|
| |
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, or Osteosarcoma
|
|
|
|
Phase III
|
|
|
|
COG-ACCL0431
COG-ACCL0431, ACCL0431, NCT00716976
|
|
| |
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
|
|
|
|
Phase III
|
|
|
|
OS2008
NCT00667342
|
|
| |
Samarium Sm 153 Lexidronam Pentasodium and Autologous Stem Cell Transplant Followed By Radiation Therapy in Treating Patients With Recurrent or Refractory, Metastatic, or Unresectable Osteosarcoma
|
|
|
|
Phase II
|
|
|
|
JHOC-J0347
JHOC-03090802, NCT00245011
|
|
| |
Radiation Therapy to Treat Musculoskeletal Tumors
|
|
|
|
Phase II
|
|
|
|
RTSARC
NCT00186992
|
|
| |
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
|
|
|
|
Phase II
|
|
|
|
CINJ-3330
NCT00161187
|
|
| |
Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas
|
|
|
|
Phase II
|
|
|
|
05-326
NCT00592293
|
|
| |
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
|
|
|
|
Phase I
|
|
|
|
2004-0079
NCT00502892
|
|
| |
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
|
|
|
|
No phase specified
|
|
|
|
JHOC-J0685
NA_00003073, J0685, NCT00499733
|
|
| |
Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
|
|
|
|
No phase specified
|
|
|
|
93-141
NCT00579930
|
|
